{"mainPropery":{"diseaseId":7158,"diseaseName":"N-acetylglutamate synthase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7158/n-acetylglutamate-synthase-deficiency","synonyms":["Hyperammonemia due to N-Acetylglutamate Synthetase Deficiency","NAGS deficiency","NAG synthetase deficiency","N-acetyl glutamate synthetase deficiency"],"synonyms-with-source":[{"name":"Hyperammonemia due to N-Acetylglutamate Synthetase Deficiency"},{"name":"NAGS deficiency"},{"name":"NAG synthetase deficiency"},{"name":"N-acetyl glutamate synthetase deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"237310"},{"identifierType":"ORPHANET","identifierId":"927"},{"identifierType":"UMLS","identifierId":"C0268543"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":381,"resourceName":"National Urea Cycle Disorders Foundation","abbreviation":"","address1":"75 South Grand Avenue","address2":"","address3":"","address4":"","address5":"","city":"Pasadena","state":"CA","zip":"91105","country":"United States","phone":"+1-626-578-0833","tty":"","tollFree":"800-38-NUDCF (386-8233)","fax":"","email":"info@nucdf.org","url":"http://www.nucdf.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/237310' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=nags%5BAll%20Fields%5D%20AND%20%28%22deficiency%22%5BSubheading%5D%20OR%20%22deficiency%22%5BAll%20Fields%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss N-acetylglutamate synthase deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=nacetylglutamatesynthasedeficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on N-acetylglutamate synthase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":415,"resourceId":1223,"resourceName":"National Urea Cycle Disorder 2011 Conference","descriptionText":"<a href='http://www.nucdf.org/events.htm ' target='_blank'>Reaching for a Cure: 2011 NUCDF Annual Conference</a>, July 8 2011 - July 10, 2011 <br /><strong>Location: </strong>Sheraton Denver Downtown, Denver, Colorado <br /><strong>Description: </strong>This conference offers the unique opportunity to meet other UCD families, stay informed, and learn about new advances in research, treatment and management to improve the lives of children and adults with UCD. Working together, our NUCDF families and community of committed researchers and medical professionals are making a major impact with advances in the understanding of UCDs, accelerating research, and improved outcomes in children and adults with UCD. In the past four years, research for UCDs has increased by 400%! Let's continue the momentum and end the devastating effects of UCD. ","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":725,"resourceId":1420,"resourceName":"RDCRN - Urea Cycle Disorders Consortium Registry","descriptionText":"<p>The <a href='https://www.rarediseasesnetwork.org/cms/ucdc' target='_blank'>Urea Cycle Disorders Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the US, working together to improve the lives of people with Urea Cycle Disorders. The Urea Cycle Disorders Consortium maintains a registry for patients who wish to be contacted about clinical research opportunities. </p><p style=\"LINE-HEIGHT: normal\">For more information on the registry see: <a href='http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm ' target='_blank'>http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm</a> </p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":791,"resourceId":1472,"resourceName":"GeneReview - Urea cycle disorders","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1217/' target='_blank'>GeneReviews</a> provides a current, expert-authored, peer-reviewed, full-text article urea cycle disorders in general that you may find helpful. GeneReview articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":792,"resourceId":1473,"resourceName":"MedlinePlus - Urea cycle disorders","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm ' target='_blank'>MedlinePlus.gov</a> provides more information on urea cycle disorders in general. MedlinePlus is a Web site designed by the National Library of Medicine to help you research your health questions.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/n-acetylglutamate-synthetase-deficiency/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/941090' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=927' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=3370&Disease(s)%20concerned=Hyperammonemia-due-to-N-acetylglutamate-synthetase-deficiency--NAGS-deficiency-&search=ResearchTrials_ResearchProjects_Simple&ChdId=3370&ResearchTrials_ResearchTrials_ResearchProjects_diseaseGroup=NAGS-deficiency&ResearchTrials_ResearchTrials_ResearchProjects_diseaseType=Pat&ResearchTrials_ResearchTrials_ResearchProjects_country=NN&ResearchTrials_ResearchTrials_ResearchProjects_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=3370&Disease(s)%20concerned=Hyperammonemia-due-to-N-acetylglutamate-synthetase-deficiency--NAGS-deficiency-&search=ClinicalLabs_Search_Simple&ChdId=3370&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=NAGS-deficiency&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_NAGSdeficiency-enPro3370.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1756,"resourceId":2916,"resourceName":"NORD Physician Guide","descriptionText":"The <a href='https://rarediseases.org/physician-guide/urea-cycle-disorders/' target='_blank'>NORD Physician Guide</a> for N-acetylglutamate synthase deficiency was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. &nbsp;The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.&nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1846,"resourceId":3031,"resourceName":"Genetics Education Materials for School Success","descriptionText":"The <a href='http://www.gemssforschools.org/conditions/urea-cycle/default' target='_blank'>Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Education Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:237310' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/urea-cycle-disorders' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2163,"resourceId":3372,"resourceName":"Good Days","descriptionText":"<a href='https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload' target='_blank'>Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2336,"resourceId":381,"resourceName":"National Urea Cycle Disorders Foundation","descriptionText":"The&nbsp;<a href='http://www.nucdf.org/ucd.htm' target='_blank'>National Urea Cycle Disorders Foundation</a>, a nonprofit organization that supports urea cycle disorders, offers information on urea cycle disorders, including&nbsp;N-acetylglutamate synthase deficiency","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":2859,"questionText":"What is&nbsp;N-acetylglutamate synthase deficiency?","answerText":"<strong>N-acetylglutamate synthase deficiency</strong>&nbsp;(NAGS) is type of metabolic disorder that affects the processing of proteins and removal of ammonia from the body. When proteins are processed by the body,  ammonia is formed. Individuals with NAGS are not able to remove ammonia from the body and have symptoms due to toxic levels of ammonia that build up in the blood. NAGS and other similar disorders are a type of metabolic condition known as a&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm\" target=\"_blank\">urea cycle disorder</a>.[1869][6174]&nbsp;<br />\r\n<br />\r\nSigns and symptoms in newborns with NAGS may include a lack of energy, unwillingness to eat, seizures, unusual body movements, and poorly controlled breathing or body temperature. Complications may include coma, developmental delay, and learning disability. Some people have a less severe form of the deficiency with earliest symptoms&nbsp;manifesting later in life, particularly following high-protein meals, illness, or other stress. Signs and symptoms may include sudden vomiting, lack of coordination, confusion, and&nbsp;coma. NAGS is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene=nags\" target=\"_blank\"><em>NAGS </em>gene</a>&nbsp;and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion. Treatment may include maintaining a low protein diet and using medications that provide alternative routes to remove ammonia from the body.[1869][3106]","dateModified":"2017-04-12T00:00:00"},"basicQuestions":[{"questionId":3057,"questionText":"How is N-acetylglutamate synthase deficiency (NAGS) inherited?","answerText":"NAGS is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene=nags\" target=\"_blank\"><em>NAGS </em>gene</a>&nbsp;and is inherited in an autosomal recessive manner.[1869] This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:<br />\r\n<ul>\r\n    <li>25% chance to be affected</li>\r\n    <li>50% chance to be an unaffected carrier like each parent</li>\r\n    <li>25% chance to be unaffected and not a carrier</li>\r\n</ul>","dateModified":"2017-04-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1869,"authors":"","articleTitle":"N-acetylglutamate synthase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"October 2006","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=nacetylglutamatesynthasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":7837,"relatedDiseaseName":"Urea cycle disorders","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":25722,"abbreviatedInquiry":"How is N-acetylglutamate synthase deficiency inherited? Are there any new research studies enrolling people with N-acetylglutamate synthase deficiency? How can&nbsp;I get my&nbsp;loved one&nbsp;seen at the National Institutes of Health?","caseQuestions":[{"questionId":2859,"questionText":"What is&nbsp;N-acetylglutamate synthase deficiency?","answerText":"<strong>N-acetylglutamate synthase deficiency</strong>&nbsp;(NAGS) is type of metabolic disorder that affects the processing of proteins and removal of ammonia from the body. When proteins are processed by the body,  ammonia is formed. Individuals with NAGS are not able to remove ammonia from the body and have symptoms due to toxic levels of ammonia that build up in the blood. NAGS and other similar disorders are a type of metabolic condition known as a&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm\" target=\"_blank\">urea cycle disorder</a>.[1869][6174]&nbsp;<br />\r\n<br />\r\nSigns and symptoms in newborns with NAGS may include a lack of energy, unwillingness to eat, seizures, unusual body movements, and poorly controlled breathing or body temperature. Complications may include coma, developmental delay, and learning disability. Some people have a less severe form of the deficiency with earliest symptoms&nbsp;manifesting later in life, particularly following high-protein meals, illness, or other stress. Signs and symptoms may include sudden vomiting, lack of coordination, confusion, and&nbsp;coma. NAGS is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene=nags\" target=\"_blank\"><em>NAGS </em>gene</a>&nbsp;and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion. Treatment may include maintaining a low protein diet and using medications that provide alternative routes to remove ammonia from the body.[1869][3106]","dateModified":"2017-04-12T00:00:00","references":[{"referenceId":1869,"authors":"","articleTitle":"N-acetylglutamate synthase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"October 2006","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=nacetylglutamatesynthasedeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3106,"authors":"Mew NA, Lanpher BC, Gropman A, Chapman KA, Simpson KL, Summar ML","articleTitle":"Urea Cycle Disorders Overview","bookWebsiteJournalTitle":"GeneReviews","date":"April 9, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1217/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6174,"authors":"","articleTitle":"What is a Urea Cycle Disorder?","bookWebsiteJournalTitle":"National Urea Cyle Disorders Foundation","date":"","volume":"","pages":"","url":"http://www.nucdf.org/ucd.htm","dateAccessed":"2017-04-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3057,"questionText":"How is N-acetylglutamate synthase deficiency (NAGS) inherited?","answerText":"NAGS is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene=nags\" target=\"_blank\"><em>NAGS </em>gene</a>&nbsp;and is inherited in an autosomal recessive manner.[1869] This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:<br />\r\n<ul>\r\n    <li>25% chance to be affected</li>\r\n    <li>50% chance to be an unaffected carrier like each parent</li>\r\n    <li>25% chance to be unaffected and not a carrier</li>\r\n</ul>","dateModified":"2017-04-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1869,"authors":"","articleTitle":"N-acetylglutamate synthase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"October 2006","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=nacetylglutamatesynthasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2861,"questionText":"Are there any new research studies enrolling people with N-acetylglutamate synthase deficiency (NAGS)?&nbsp;How can I get my loved one&nbsp;seen at the National Institutes of Health?\r\n<p>&nbsp;</p>","answerText":"There may be clinical trials and research studies enrolling people with NAGS. Instructions on finding these studies are provided below.<br />\r\n<br />\r\nThe&nbsp;<a href=\"http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm\" target=\"_blank\">Urea Cycle Disorders Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the US, working together to improve the lives of people with Urea Cycle Disorders. The purpose of this consortium is to provide a way for patients to join with doctors and researchers by participating in research studies. The greater the collaboration between doctors and patients, the more we can learn about Urea Cycle Disorders.To read more about the&nbsp;contact registry, please click on the&nbsp;UCDC link above.<br />\r\n<br />\r\nUrea Cycle Disorders Consortium Registry<br />\r\nChildren's National Medical Center<br />\r\nPhone: 815-333-4014<br />\r\nEmail: <a href=\"mailto:jseminar@cnmc.org\">jseminar@cnmc.org</a>\r\n<p><span style=\"font-size: 12pt;\">Patients are typically seen at the NIH through participation in clinical trials. Clinical trials are medical research studies in which people participate as volunteers. They are a means of developing new treatments and medications for diseases and conditions. There are strict rules for clinical trials, which are monitored by the National Institutes of Health (NIH) and the U.S. Food and Drug Administration.</span></p>\r\n<p>Some of the research studies at the <a href=\"http://www.cc.nih.gov/ccc/crc/\">NIH Clinical Center</a> involve promising new treatments that may directly benefit patients. The Clinical Center does not charge patients for participation and treatment in clinical studies conducted at the NIH.&nbsp; In certain emergency circumstances, you may qualify for help with travel and other expenses. </p>\r\n<p>You can search a database of clinical trials being conducted by the NIH at the Clinical Center in Bethesda, Maryland at the following link. You can also contact the Patient Recruitment and Public Liaison Office directly at 1-800-411-1222 to speak with a specialist, who can help you determine if you are eligible for any clinical trials.<br />\r\n<a href=\"http://clinicalstudies.info.nih.gov/\">http://clinicalstudies.info.nih.gov/</a>&nbsp; </p>\r\n<p>In addition, the NIH through the National Library of Medicine has developed <a href=\"http://clinicaltrials.gov/\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies.&nbsp; You can search this database to find clinical trials at the NIH Clinical Center as well as federally and privately supported trials being conducted at universities and medical centers throughout the United States and around the world. To find clinical trials, click on the link above and use \"urea cycle disorders\" or \"N-acetylglutamate synthase deficiency\" as your search term. </p>\r\n<p>When you find a study of interest, review its \"eligibility\" criteria to determine its appropriateness. Use the study's contact information to learn more. Check these sites often for regular updates.</p>\r\n<p>If you are interested in enrolling your loved one&nbsp;in a clinical trial, you can find helpful general information on clinical trials at the following ClinicalTrials.gov Web page. <br />\r\n<a href=\"http://clinicaltrials.gov/ct2/info/understand\">http://clinicaltrials.gov/ct2/info/understand</a></p>\r\n<p>Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the Office of Rare Diseases (ORD), National Institutes of Health.<br />\r\n<span style=\"text-decoration: underline;\"><a href=\"http://rarediseases.info.nih.gov/Resources.aspx?PageID=8\">http://rarediseases.info.nih.gov/Resources.aspx?PageID=8</a></span></p>\r\n<p>In addition, you can find research studies involving N-acetylglutamate synthase deficiency by searching the <a href=\"http://projectreporter.nih.gov/reporter.cfm\" target=\"_blank\">Research Portfolio Online Reporting Tool (RePORT)</a>. RePORT provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.&nbsp; Although these projects&nbsp;may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, click on the link above and enter \"urea cycle disorder\" or \"N-acetylglutamate synthase deficiency\" in the &ldquo;Terms Search&rdquo; box.&nbsp; Then click &ldquo;Submit Query&rdquo;.</p>","dateModified":"2017-04-12T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3425,"phenoTypeName":"Infantile muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15400,"phenoTypeName":"Acute hyperammonemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6010,"phenoTypeName":"Agitation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11416,"phenoTypeName":"Drowsiness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13239,"phenoTypeName":"Feeding difficulties","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3994,"phenoTypeName":"Hyperalaninemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14518,"phenoTypeName":"Hyperglutaminemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1855,"phenoTypeName":"Insomnia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8511,"phenoTypeName":"Loss of consciousness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4747,"phenoTypeName":"Mood changes","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10361,"phenoTypeName":"Poor appetite","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5225,"phenoTypeName":"Poor speech","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13803,"phenoTypeName":"Cerebral ischemia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":675,"phenoTypeName":"Delirium","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11081,"phenoTypeName":"Echolalia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7953,"phenoTypeName":"Myelodysplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14239,"phenoTypeName":"Paraplegia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8730,"phenoTypeName":"Polyneuropathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6018,"phenoTypeName":"Psychotic episodes","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13728,"phenoTypeName":"Respiratory distress","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10213,"phenoTypeName":"Reye syndrome-like episodes","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6026,"phenoTypeName":"Stereotypy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9386,"phenoTypeName":"Stroke","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6013,"phenoTypeName":"Aggressive behavior","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","percentRanges":"-"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","percentRanges":"-"},{"phenoTypeId":6424,"phenoTypeName":"Increased level of L-glutamic acid in blood","percentRanges":"-"}],"medicalProducts":[{"productId":662,"genericName":"Carglumic acid","tradeName":"Carbaglu","tradeLink":"https://www.carbaglu.net/","manufacturer":"","sponsor":"Orphan Europe SARL","indication":"As an adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS) and as manitenance therapy for chronic hyperammonemia due to NAGS deficiency.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/carbaglu","medlinePlusLink":""}],"EncodedName":"N-acetylglutamate_synthase_deficiency"}